highmark glp-1 coverage Weight Loss Drugs versus Bariatric Surgery for Obesity Treatment Highmark, UPMC Health Plan coverage

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting

Relative risk of mortality and morbidity As per the non-diabetic model, but with benefits specific to the diabetic population

Some are also approved for a liver condition known as metabolic dysfunction-associated steatohepatitis (MASH)

In this way, it fills an important gap in the modern wellness market

Diabetes Obes Metab 15(1):1527 Nauck MA, DAlessio DA (2022) Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction

GLP-1 receptor agonists include injectable options like semaglutide (Ozempic), dulaglutide (Trulicity), and liraglutide (Victoza), as well as oral semaglutide (Rybelsus)